Ambulatory electrocardiographic monitoring in type 1 myotonic dystrophy;Monitorização electrocardiográfica ambulatória na distrofia miotónica do tipo 1

Revista Portuguesa de Cardiologia

Volumn 26, Issue 7-8, 2007, Pages 745-753

  Sá, Maria Isabel ^a   Cabral, Sofia ^b   Costa, P Dias ^b   Coelho, Teresa ^b   Freitas, Mário ^b   Gomes, J Lopes ^b  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^b NONE

Author keywords

Conduction tissue abnormalities; Holter; Myotonic dystrophy

Indexed keywords

AMBULATORY MONITORING; ARTICLE; ARTIFICIAL HEART PACEMAKER; CORRELATION ANALYSIS; ECG ABNORMALITY; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; FOLLOW UP; GENETIC RISK; HEART CONDUCTION; HOLTER MONITORING; HUMAN; MYOTONIC DYSTROPHY; PREDICTOR VARIABLE; PREVALENCE; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ARRHYTHMIAS, CARDIAC; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; PACEMAKER, ARTIFICIAL;

EID: 34748922268     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Fu YH, Pizzuti A , Fenwick RG Jr, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255: 1256-8.
2. The International Myotonic Dystrophy Consortium (IDMC). New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). Neurology 2000;54:1218-21.
3. Hawley RJ, Milner MR, Gottdiener JS, et al. Myotonic heart disease. A clinical follow-up. Neurology 1991;41:259-62.
4. Fragola PV, Luzi M, Calo L, et al. Cardiac involvement in myotonic dystrophy. Am J Cardiol 1994;74:1070-2.
5. Colleran JA, Hawley RJ, Pinnow EE, et al. Value of the electrocardiogram in determining cardiac events and mortality in myotonic dystrophy. Am J Cardiol 1997;80:1494-7.
6. Merlevede K, Vermander D, Theys P, et al. Cardiac involvement and CTG expansion in myotonic dystrophy. J Neurol (2002) 249 : 693-698
7. Melacini P, Villanova C, Menegazzo E, et al. Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J Am Coll Cardiol 1995;25:239-45.
8. Tokgozoglu LS, Ashizawa T, Pacifico A, et al. Cardiac involvement in a large kindred with myotonic dystrophy. Quantitative assessment and relation to size of CTG expansion. JAMA 1995;274:813-19.
9. Sá MI, Reis AH, Lagarto V, et al. Alterações cardíacas na distrofia miotónica tipo 1. Revista Portuguesa de Cardiologia 2005;24, (supl. I): I-85.
10. Clarke NRA, Kelion AD, Nixon J, Hilton-Jones D, Forfar JC. Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy? Heart 2001;86:411-416
11. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee on Pacemaker Implantation). 2002
12. Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc Res 1997;33:13-22.
13. Church S. The heart in myotonia atrophica. Arch Intern Med1967;119:176-81.
14. Prystowsky EN, Pritchett EIC, Roses A, et al. The natural history of conduction system disease in myotonic muscular dystrophy as determined by serial electrophysiologic studies. Circulation 1979;60:1360-4.
15. Nishioka SA, Filho MM, Marie S, et al. Myotonic Dystrophy and Heart Disease. Behavior of Arrhythmic Events and Conduction Disturbances. Arq Bras Cardiol. 2005 Apr;84(4):330-6.
16. Hadian D, Lowe MR, Scott LR, et al. Use of an insertable loop recorder in a myotonic dystrophy patient. J Cardiovasc Electrophysiol 2002;13:72-3.
17. Lazarus A, Varin J, Ounnoughene Z, Radvanyi H, Junien C, Coste J, Laforet P, Eymard B, Becane HM, Weber S, Duboc D. Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation 1999: 1041-1046.
18. Pelargonie G, Russo AD, Sanna T, et al. Myotonic dystrophy and the heart. Heart 2002;88;665-670
19. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48:e247-e346.